This review describes the current challenges and recommendations in the transfusion management of thalassemia patients. In addition, it reviews the components of blood safety and blood product modification in special populations. Adverse transfusion reactions are described as are some of the newer technologies being utilized to reduce potential transfusion-associated pathogens. Lastly, research in blood storage and in manufactured blood is briefly described.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/nyas.15049 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!